Number of Shares
286.00
Current Holdings Value*
$171,250.00
% of Portfolio
3.59%
Total Estimate Gain
$-48,400.29
% of Total Estimate Gain
-19.79%

Putnam BioRevolution ETF's Regeneron Pharmaceuticals Inc Holding Summary

As of 2025-04-30, Putnam ETF Trust held 286.00 shares of Regeneron Pharmaceuticals Inc(REGN), totaling $171,250.00. This investment constitutes 3.59% of their stock portfolio, and Putnam ETF Trust now holds 0% of the outstanding Regeneron Pharmaceuticals Inc(REGN) stock.

The initial trade took place in 2022Q4. And since then Putnam BioRevolution ETF has made 4 purchases of REGN, at an average price of $743.46, for a total of 329.00 shares. In addition, there have been 2 sales at an average price of $831.90 for 43.00 shares. Based on historical transaction data and REGN's current price of $560.93, Putnam BioRevolution ETF's estimated gain on his REGN holdings is $-48,400.29, reflecting a -19.79% gain to date.

Putnam BioRevolution ETF REGN ($560.93) Holding Chart

Putnam BioRevolution ETF REGN ($560.93) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1